HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Rule Seeks To Eliminate Potential For Spreading BSE In Cosmetics

This article was originally published in The Rose Sheet

Executive Summary

FDA will prohibit use of materials from "downer" and dead cattle in cosmetics in an effort to minimize public exposure to bovine spongiform encephalopathy

You may also be interested in...



FDA BSE Rule Permits Tallow With .15% Hexane-Insoluble Impurities

FDA's 1interim final rule prohibiting certain bovine risk materials in cosmetics, dietary supplements and foods to minimize exposure to bovine spongiform encephalopathy will be effective immediately upon publication in the Federal Register, slated for July 14

FDA BSE Rule Permits Tallow With .15% Hexane-Insoluble Impurities

FDA's 1interim final rule prohibiting certain bovine risk materials in cosmetics, dietary supplements and foods to minimize exposure to bovine spongiform encephalopathy will be effective immediately upon publication in the Federal Register, slated for July 14

China To Resume U.S. Cosmetic Imports Based On Certification

China will resume importing cosmetics from the U.S. provided they include export certificates demonstrating the products do not contain animal-related ingredients prohibited in China, FDA announced April 21

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011858

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel